UM Miller School of Medicine: New Grant Funding Aims to Quell Pancreatic Cancer With Immunotherapy
June 29, 2024
June 29, 2024
MIAMI, Florida, June 29 (TNSres) -- The University of Miami's Miller School of Medicine issued the following news:
By Charlotte Schubert
The advent of immunotherapy has made a big difference in the lives of many patients with blood cancers and some solid tumor types, like melanoma and lung cancer.
But one particularly lethal type of cancer is poorly responsive to immunotherapy, as well as a host of other treatments -- pancreatic cancer. Only about 13% of pe . . .
By Charlotte Schubert
The advent of immunotherapy has made a big difference in the lives of many patients with blood cancers and some solid tumor types, like melanoma and lung cancer.
But one particularly lethal type of cancer is poorly responsive to immunotherapy, as well as a host of other treatments -- pancreatic cancer. Only about 13% of pe . . .